$0.920
-0.029 (-3.16%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
GDTC 相似图表分析预测
Alphio's GDTC stock price prediction model matches the current CytoMed Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.99 (+7.67%). The 1-week path is $0.99 (+7.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 CytoMed Therapeutics Ltd 股票吗？
CytoMed Therapeutics Ltd (GDTC) is not a good buy right now due to its significant downward trends and poor financial metrics. The current price is $0.92, which is down 33.81% year-to-date and 54.11% over the past year. Additionally, the stock has a negative P/E ratio of -1.91 and a forward P/E of 0, indicating a lack of profitability and future earnings potential. The RSI is at 46.19, suggesting the stock is neither overbought nor oversold, but the overall trend is negative. The main risk is the 5-day change of -10.68%, indicating a recent sharp decline in value.
GDTC 股价于 Friday 收于 $0.92，此前下跌 -3.16%
CytoMed Therapeutics Ltd (GDTC) last closed at $0.92, losing -3.16%. These facts feed the 1-day and 1-week GDTC price prediction above.
预测驱动因素
CytoMed Therapeutics Ltd（GDTC）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 GDTC 最接近的股票，按相似度排序。
GDTC 季节性分析
Historically the probability of a positive August return for GDTC is 0.00%. January offers the highest probability of a positive month at 4.92%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。